An Enhanced SMS Text Message–Based Support and Reminder Program for Young Adults With Type 2 Diabetes (TEXT2U): Randomized Controlled Trial
Open accessPublished version of a preprint
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index; none of the 39 sources its claims cite is checked for support yet.
Abstract
Background: Clinic attendance, metabolic control, engagement in self-management, and psychological health are suboptimal in young-onset (age of onset <40 years) type 2 diabetes. Objective: We examined the effectiveness of an enhanced SMS text message–based support and reminder program in improving clinic attendance, metabolic control, engagement in self-management, and psychological health in young-onset type 2 diabetes. Methods: A 12-month, parallel-arm, randomized controlled trial comparing an enhanced, semipersonalized SMS text message–based intervention (incorporating 1-8 supportive and/or informative text messages per month) against standard care was conducted in a specialized clinic for young adult type 2 diabetes. The primary outcome was maintenance of 100% attendance at scheduled quarterly clinical appointments. Secondary outcomes included (1) metabolic indices, (2) pathology and self-monitored blood glucose (SMBG) data availability, and (3) psychosocial well-being. Results: A total of 40 participants were randomized, and 32 completed their 12-month study visit. The average participant age was 32.7 (SD 5.1) years, 50% (20/40) were male, and baseline glycated hemoglobin A1c (HbA1c) was 7.3% (SD 1.9%) (56 mmol/mol, SD 20). A higher proportion of the intervention group achieved 100% attendance (12/21, 57%, vs 5/19, 26%, for the control group); Kaplan-Meier analysis demonstrated significantly greater cumulative attendance in the intervention group (P=.04). There were no between-group differences in HbA1c, BMI, lipids, or availability of pathology and SMBG data. Odds of recording an improvement in the Diabetes Empowerment Scale–Short Form score were higher in the intervention group at 6 months (odds ratio [OR] 4.3, 95% CI 1.1-17), with attenuation of this effect at study end (OR 3.1, 95% CI 0.9-11). Program acceptability was high; >90% of participants would recommend the program to new patients. Conclusions: An enhanced SMS text message–based support and reminder program doubled scheduled clinic attendance rates for patients with young-onset type 2 diabetes. The program was highly acceptable and provided early support for patient empowerment but had no significant effect on measures of metabolic control or self-management. Trial Registration: Australian and New Zealand Clinical Trials Registry (ACTRN12618000479202); https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373579
Overview
CoChat Summary
TL;DR
In a 12-month RCT in young-onset type 2 diabetes, an enhanced semipersonalized SMS support and reminder program more than doubled 100% scheduled clinic attendance versus standard care and improved diabetes self-efficacy at 6 months, but did not improve metabolic control or self-management measures. The program was highly acceptable and reduced rescheduling administrative burden.
Key findings
- Primary attendance outcome: 12/21 (57%) intervention participants vs 5/19 (26%) control participants achieved 100% attendance at scheduled quarterly clinic appointments; Kaplan-Meier analysis showed significantly greater cumulative attendance in the intervention group (log-rank P=.04). Overall scheduled attendance was 64/84 (76%) vs 44/76 (58%), and 18% fewer rescheduling interventions were needed in the intervention group.
- No between-group differences were found in HbA1c, BMI, lipids, or availability of pathology and self-monitored blood glucose (SMBG) data. At 12 months, mean HbA1c was 7.1% (SD 1.1) in the intervention group vs 6.6% (SD 1.7) in the control group (P=.37); SMBG data were available at 40% vs 37% of appointments, pathology data at 69% vs 66%, with ORs 1.2 (95% CI 0.4-3.1) and 1.1 (95% CI 0.4-3.2), respectively.
- Diabetes Empowerment Scale–Short Form (DES-SF) improvement at 6 months occurred in 68% (13/19) of the intervention group vs 31% (5/16) of the control group (P=.03); the odds of a positive DES-SF change were higher in the intervention group at 6 months (OR 4.3, 95% CI 1.1-17), with attenuation at 12 months (OR 3.1, 95% CI 0.9-11). No significant between-group differences were found for PAID-5 or DSAS-2 scores.
- Acceptability was high: >90% of participants would recommend the program to new patients; 94% (15/16) of survey respondents reported the messages contained practical information and motivated them to think about diabetes management, and 94% (15/16) would recommend it to all new patients. Of 21 intervention participants, 20 received all study text messages, 11 used the optional SMS portal, and the median number of participant-sent messages was 3 (range 1-29).
Methods
- A 12-month, parallel-arm, investigator-blinded randomized controlled trial at the Royal Prince Alfred Hospital Diabetes Centre enrolled participants with young-onset type 2 diabetes (age of onset 18-40 years) who had mobile phone access and sufficient English proficiency. Recruitment occurred March-August 2018; 40 participants were randomized 1:1 using block randomization (block size 4), and 32 completed the 12-month visit. Mean age was 32.7 (SD 5.1) years, 50% (20/40) were male, and baseline HbA1c was 7.3% (SD 1.9%) (56 mmol/mol, SD 20).
- The intervention added a semipersonalized SMS support and reminder program to standard care, with 1-8 messages per month: two messages per week for the first 2 months, one per week in month 3, then one per month thereafter; a personalized appointment reminder was sent in the week before each follow-up appointment, and an optional SMS portal allowed participants to message the study team. The control group received standard care, including generic SMS appointment reminders.
- The primary outcome was 100% attendance at scheduled quarterly clinical appointments, analyzed with Kaplan-Meier methods and the log-rank test. Secondary outcomes included metabolic indices, pathology and SMBG data availability, and psychosocial measures (PAID-5, DES-SF, DSAS-2) at baseline, 6 months, and 12 months; analyses used ANOVA, Pearson chi-squared tests, binary logistic regression, and a general estimating equations framework in SPSS version 24.0, with two-tailed tests at α=.05. The study was powered to detect a difference in clinic attendance, not small differences in secondary outcomes.
Limitations
- The paper states that the study was powered to detect a difference in clinic attendance but not small differences in secondary outcomes; it was conducted at a single secondary/tertiary referral center with a modest number of participants, limiting generalizability. The cohort was well educated (80% had attended or were attending TAFE/university), so testing in lower-literacy groups is needed; the study focused on younger adults, so applicability to older age groups is uncertain; and although all participants had sufficient English proficiency, native-language provision might have improved engagement. The paper also states that blinding both participants and treating clinicians was not possible by design, though treating-clinician blinding and an objectively measured primary endpoint were intended to mitigate observer bias.
- Evident from the text: the sample was small and 8/40 participants did not complete the 12-month visit; missing data were not imputed; absolute pharmacotherapy adherence was not actively assessed; no formal cost-benefit analysis was undertaken; and the end-of-study acceptability survey included only 16/21 intervention participants, with nonresponders being younger, heavier, and having slightly lower baseline HbA1c.
- Evident from the text: overall attendance after makeup appointments was equal between groups (boosted to 80% in both), which may explain the lack of metabolic differences; the intervention reduced but did not eliminate nonattendance, with just over half of the intervention group and one-quarter of the control group achieving 100% attendance.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
0 Valid · 1 Not valid · 30 Not checked · 105 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The requirement for this extra administrative burden was lower in the intervention group; 18% fewer rescheduling interventions were necessary in this group.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“68% (13/19) of members of the intervention group recorded a favorable change in DES-SF score at 6 months, versus 31% (5/16) in the control group (P=.03)”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“If the analysis was restricted to those with 100% attendance, the change in HbA1c from baseline to study end was –0.58% (95% CI –1.70 to 0.59) (intervention) and –0.18% (95% CI –0.46 to 0.10) (control).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Binary logistic regression modeling revealed no evidence of a difference in the odds of recording a positive change in PAID‑5 or DSAS-2 scores for the intervention and control groups”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“with attenuation of this effect at study end (OR 3.1, 95% CI 0.9-11)”
plainn = 40- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
58 more claims
Create a free account to see all 136 claims and to verify the 18 references still open.
- Probably not a substantial claim. 46
- It may state two separate claims as one. 36
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“No considerable differences were reported on diabetes distress in two studies, p‐value = 0.881, 20 ; p‐value = 0.76, 28”
From Effectiveness of self‐management interventions on Type 2 diabetes among young adults (18–45 years): A systematic review and meta‐analysis (2025) · cites this paper as [28]
In the citing paper
“triglycerides: pooled MD; −26.391 mg/dL; 95% CI; −60.586 to 7.803; p‐value = 0.130.”
From Effectiveness of self‐management interventions on Type 2 diabetes among young adults (18–45 years): A systematic review and meta‐analysis (2025) · cites this paper as [28]
In the citing paper
“The pooled standardised MD; 0.427; 95% CI; −0.267 to 1.121 was not statistically significant (p‐value = 0.228).”
From Effectiveness of self‐management interventions on Type 2 diabetes among young adults (18–45 years): A systematic review and meta‐analysis (2025) · cites this paper as [28]
In the citing paper
“total cholesterol‐pooled: MD; −2.815 mg/dL; 95% CI; −15.897 to 10.268; p‐value = 0.673”
From Effectiveness of self‐management interventions on Type 2 diabetes among young adults (18–45 years): A systematic review and meta‐analysis (2025) · cites this paper as [28]
In the citing paper
“or stigma scores (p‐value = 0. 46) 28”
From Effectiveness of self‐management interventions on Type 2 diabetes among young adults (18–45 years): A systematic review and meta‐analysis (2025) · cites this paper as [28]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Results
“For those with 12-month follow-up data (20/21 intervention and 15/19 control, respectively)”
§ Results
“Of the 21 SMS group participants, 5 did not attend their scheduled 12-month follow-up clinic visit (or a makeup appointment for their missed clinic visit)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“25% (19/74) of messages directed a diabetes-specific question to the study team or sought clarification regarding some aspect of diabetes management”
Reported 25 · recomputed 25.675676
Citations
Cites
The REDCap consortium: building an international community of software platform partners
Harris, P. A., Taylor, R., Minor, B. L., Elliott, V., Fernandez, M., O'Neal, L., McLeod, L., Delacqua, G., Delacqua, F., Kirby, J., et al. (2019) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2019.103208 · Cited by 24,013
Charles, C., Gafni, A., & Whelan, T. (1999) · Social Science & Medicine · doi:10.1016/s0277-9536(99)00145-8 · Cited by 2,333
Expanding Patient Involvement in Care: Effects on Patient Outcomes
GREENFIELD, S., KAPLAN, S., & WARE, J. E. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-4-520 · Cited by 1,413
Patients’ Memory for Medical Information
Kessels, R. P. C. (2003) · Journal of the Royal Society of Medicine · doi:10.1177/014107680309600504 · Cited by 1,348
Osborne, R. H., Batterham, R. W., Elsworth, G. R., Hawkins, M., & Buchbinder, R. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-658 · Cited by 1,334
A Clinical Trial to Maintain Glycemic Control in Youth with Type 2 Diabetes
TODAY Study Group (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109333 · Cited by 971
Kelley, J. M., Kraft-Todd, G., Schapira, L., Kossowsky, J., & Riess, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094207 · Cited by 902
Dabelea, D., Stafford, J. M., Mayer-Davis, E. J., D’Agostino, R., Dolan, L., Imperatore, G., Linder, B., Lawrence, J. M., Marcovina, S. M., Mottl, A. K., et al. (2017) · JAMA · doi:10.1001/jama.2017.0686 · Cited by 700
Chow, C. K., Redfern, J., Hillis, G. S., Thakkar, J., Santo, K., Hackett, M. L., Jan, S., Graves, N., de Keizer, L., Barry, T., et al. (2015) · JAMA · doi:10.1001/jama.2015.10945 · Cited by 676
Self-citationEfficacy of text messaging-based interventions for health promotion: A meta-analysis
Head, K. J., Noar, S. M., Iannarino, N. T., & Grant Harrington, N. (2013) · Social Science & Medicine · doi:10.1016/j.socscimed.2013.08.003 · Cited by 654
Research works printed but not linked: 2
- 10.1002/(sici)1096-9136(1998110)15:3+<s14::aid-dia725>3.3.co;2-9 · doi:10.1002/(sici)1096-9136(1998110)15:3+<s14::aid-dia725>3.3.co;2-9
- Kessels, RPC, 2003, J R Soc Med, 96, 219
Cited by
Zhang, A., Wang, J., Wan, X., Zhang, Z., Zhao, S., Guo, Z., & Wang, C. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19074173 · Cited by 50
“Forjuoh (2014) [51] Y Y Y Y Y Timothy Middleton (2021) [40] Y Y Y Y Y A.”
BackgroundResultInfluentialZhang, X., Zhang, L., Lin, Y., Liu, Y., Yang, X., Cao, W., Ji, Y., & Chang, C. J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1068254 · Cited by 32
Don’t Forget the Humble Text Message: 25 Years of Text Messaging in Health
Dobson, R., Whittaker, R., Abroms, L. C., Bramley, D. M., Free, C., McRobbie, H. J., Stowell, M., & Rodgers, A. (2024) · Journal of Medical Internet Research · doi:10.2196/59888 · Cited by 28
Tanhapour, M., Peimani, M., Kalhori, S. R. N., Nasli‐Esfahani, E., Shakibian, H., Mohammadzadeh, N., & Qorbani, M. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02133-9 · Cited by 19
Sherman, K. A., Pehlivan, M., Redfern, J., Armour, M., Dear, B. F., Singleton, A. C., Duckworth, T. J., Ciccia, D., Cooper, M. J. W., Hawkey, A., et al. (2023) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2023.101093 · Cited by 17
The effectiveness of telemedicine in the management of type 2 diabetes: A systematic review
Dat, T. V., Binh, V., Hoang, T. M., Tu, V. L., Luyến, P. Đ., & Le, A. T.-K. (2024) · SAGE Open Medicine · doi:10.1177/20503121241271846 · Cited by 15
Khavere, S., Hadjiconstantinou, M., Miksza, J., Hagan, J., Salisu‐Olatunji, S., Naderpour, S., Hassen, S. N., Karimi, Z., & Gillies, C. L. (2025) · Diabetic Medicine · doi:10.1111/dme.70127 · Cited by 10
Singleton, A. C., Raeside, R., Hyun, K. K., Hayes, M., Sherman, K. A., Elder, E. E., Redfern, J., & Partridge, S. R. (2023) · Journal of Medical Internet Research · doi:10.2196/45164 · Cited by 10
Yu, J., Fu, Y., Du, H., Wu, Q., Zhang, S., Zhao, B., Xue, E., Guo, Y., Yang, R., Zhu, M., et al. (2025) · Health Psychology Review · doi:10.1080/17437199.2025.2532017 · Cited by 9
Kelly, F. A., de Moraes, F. C. A., Lôbo, A. D. O. M., Sano, V. K. T., Souza, M. E. C., de Almeida, A. M., Kreuz, M., Laurinavicius, A. G., & Consolim‐Colombo, F. M. (2024) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x241298169 · Cited by 9
Bray, L., Chew-Graham, C. A., Polidano, K., Fisher, T., Farmer, A. D., McDermott‐Hughes, M., & Saunders, B. (2023) · Health Expectations · doi:10.1111/hex.13845 · Cited by 7
Yan, A., Staab, E. M., Nuñez, D., Zhu, M., Wan, W., Schaefer, C. T., Campbell, A., Quinn, M. T., & Baig, A. A. (2024) · JMIR Diabetes · doi:10.2196/55473 · Cited by 7
Pirouzmand, N., Ko, G. S., Godoy, L. C., Haldenby, O., Jackevicius, C. A., Jubran, A., McNaughton, C. D., Shah, B. R., Sud, M. K., Tu, K., et al. (2025) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2025-005218 · Cited by 6
Juliani, E., Yari, Y., & Rosliany, N. (2024) · Jurnal Ilmiah Kesehatan Diagnosis · doi:10.35892/jikd.v19i1.1833 · Cited by 6
Nejamis, A., Gutiérrez, L., López, M. V., Ciganda, Á., Quispe, O. M., Irazola, V. E., & Beratarrechea, A. G. (2025) · JMIR Formative Research · doi:10.2196/81098 · Cited by 5
Digital Interventions in Type 2 Diabetes Mellitus
Salgueiro, L., de Elizalde", P., B. A., Pereyra, K., Pontificia Universidad Católica Madre y Maestra, S. D. L. C., Vargas-Martínez, C., Servicio de Cirugía General, C. L. V. Q. S., Ortega-Márquez, J., Universidad Nacional Autónoma de México, C. D. M., Callegari-Osorio, S., et al. (2023) · Principles and Practice of Clinical Research Journal · doi:10.21801/ppcrj.2023.92.5 · Cited by 4
Chen, R., Irving, M. J., Tsai, C., Christian, B., Kumar, H., Masoe, A., Prabhu, N. T., Sohn, W., Spallek, H., & Chow, C. K. (2025) · JMIR Pediatrics and Parenting · doi:10.2196/72107 · Cited by 3
Self-citationCarcone, A. I., Baskar, D., Mahmood, A., MacDonell, K. K., Eggly, S. S., Ghosh, S., Buggs‐Saxton, C., Ondersma, S. J., & Ellis, D. A. (2025) · JMIR Formative Research · doi:10.2196/75623 · Cited by 3
Research Landscape of Diabetes mHealth Technologies
Castillo-Valdez, P. F., Rodríguez-Salvador, M., & Ho, Y. (2024) · Foresight-Russia · doi:10.17323/2500-2597.2024.1.19.32 · Cited by 3
Ramadhani.F, Z., & Marlina, L. (2025) · Scientific English · doi:10.58712/se.v1i1.4 · Cited by 3
Noonan, S., Gauld, A., Constantino, M., McGill, M. J., Middleton, T. L., Caterson, I. D., Fontana, L., Twigg, S. M., Wu, T., Biswas, R. K., et al. (2025) · JMIR Diabetes · doi:10.2196/68214 · Cited by 2
Self-citationTanhapour, M., Mohammadzadeh, N., Kalhori, S. R. N., Shakibian, H., Peimani, M., & Nasli‐Esfahani, E. (2024) · Universal Access in the Information Society · doi:10.1007/s10209-024-01138-7 · Cited by 2
Pilot of interactive texting for diabetes self-management education and support
Carmichael, A., Orr, E. S., Cisneros-Orozco, A., Rynn, K. O., & Zimmermann, K. (2025) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2025.102403 · Cited by 2
Education model on SMS gateway on blood sugar levels of diabetes mellitus patients
Febriyanti, F., Yusril, V., & Guci, A. (2023) · Jurnal Keperawatan · doi:10.22219/jk.v14i01.23338 · Cited by 2
Huda, R. K., Singh, J., Kumar, P., Mandhana, L., Kumar, M., Sangwan, R. K., & Babu, B. V. (2025) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2025.102264 · Cited by 1
A spotlight on lymphoedema Did Not Attends: Demographics and workforce costs
Thomas, M., Humphreys, I., & Noble‐Jones, R. (2022) · International Wound Journal · doi:10.1111/iwj.13999 · Cited by 1
Digital Management of Early-Onset Type 2 Diabetes: Empowerment, Challenges, and Future Outlook
Guo, L.-J., Low, K.-S., Tae, S.-K., & Lim, L.-L. (2026) · Current Diabetes Reports · doi:10.1007/s11892-026-01633-6
zhu, Z., Xie, L., Mao, Y., Huang, C., Zhu, Z., Zhang, H., & Jian, M. (2026) · doi:10.2196/preprints.104337
Oliveira, D., Henriques, A., Nogueira, P., & Costa, A. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1822499
Zhu, Q., Xia, M., Zheng, S., Gao, X., Lan, X., & Lu, S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1941060
Tedong, L., Wamon, A. R. K., Kamgang, J., Dzeufiet, P. D. D., Ondoua, P. C. B., Agbor, M. A., Sone, A. N. M., & Djamen, P. D. C. (2025) · International Journal of Complementary & Alternative Medicine · doi:10.15406/ijcam.2025.18.00746
Sheahen, B., Laranjo, L., Trivedi, R., Shaw, T., Sivagangabalan, G., Chong, J. J. H., Thiagalingam, A., Zaman, S. J., Qian, P. C., Indrawansa, A. B., et al. (2026) · JMIR Cardio · doi:10.2196/68896
Self-citationHassani, A., Pecar, K. D., Soliman, M., Bunyon, P., Ellinger, C., Tulysewskid, G., Croft, J., Carillo, C., Wewegama, G., du Plessis-Schneider, S., et al. (2026) · medRxiv · doi:10.64898/2026.04.22.26351525
Evidence-Based Type 2 Diabetes Management Through Education, Technology, and Care
Kane, J. (2026) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2026.106056
Reporting Gaps in mHealth Intervention Studies for Adults With Diabetes: Systematic Review
Yue, X., Shen, J., Peng, J., Huang, X., Hu, M., & Hu, X. (2026) · JMIR mhealth and uhealth · doi:10.2196/95863
宋, 怀., Huang, Y., Li, J., Ding, Y., Xu, M., Luo, Z., Chen, M., & Cao, X. (2025) · doi:10.2196/preprints.71406
Darmawulan, N., & Emaliyawati, E. (2024) · INDONESIAN NURSING JOURNAL OF EDUCATION AND CLINIC (INJEC) · doi:10.24990/injec.v8i2.622
Metadata
- Authors
- Middleton, T., Constantino, M., McGill, M., D'Souza, M., Twigg, S. M., Wu, T., Thiagalingam, A., Chow, C., & Wong, J.
- Affiliations
- The University of Sydney (AU)
- Sydney Local Health District (AU)
- Corresponding author
- Middleton, Timothy
- ORCID
- Venue
- Journal of Medical Internet Research
- Publisher
- JMIR Publications Inc.
- Published
- 2021-10-21
- Volume
- 23
- Issue
- 10
- Pages
- e27263
- ISSN
- 1438-8871 (ISSN-L)
- PMC
- PMC8569538
- OpenAlex
- W3200853457
- Semantic Scholar
- 8ba0d44a40cc06ab3eeb00af132e34db487e686d
- Cited by
- 38
- References
- 37
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 9 · 2023: 7 · 2022: 2
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Journal of Medical Internet Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Australian Government
- Medical Research Future Fund
- Topics
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, young-onset diabetes, young adults, safety management systems, mobile health intervention, clinic attendance, metabolic control, self-management, self-monitoring of blood glucose, diabetes empowerment, psychosocial well-being, program acceptability
- MeSH terms
- Self-Management, Adult, Appointments and Schedules, Australia, Diabetes Mellitus, Type 2, Humans, Male, Young Adult, Text Messaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-20, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-20 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.